Home
About
Directors and Management
Careers
Corporate Governance
Board Charter
Code of Conduct
Audit Committee Charter
Nomination and Remuneration Committee Charter
Continuous Disclosure Policy
Share Trading Policy
Risk Management Policy
Social Media Policy
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
Whistleblower Policy
Investors
Public Disclosure Policy
ASX Announcements
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Contact
Shop évolis®
✕
2013
Home
2013
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change in Director’s Interest – M Halasz
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change in Director’s Interest – M Halasz
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
European Patent Allowed for Treating Vascular Occlusive Disease
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Positive Data in Midkine Antibody Study in Kidney Disease
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Appendix 4C Quarterly report
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Cellmid News
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Cellmid Signs Midkine Diagnostic Agreement
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change in Director’s Interest – M Rogers
November 13, 2019
Published by
Tiffany McMillan
on
November 13, 2019
Categories
Change in Director’s Interest – M Halasz
1
2
3
4
5
6
Next page
Shop évolis®
